Paula Cloghessy

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Lexington, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Mei, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Paula Cloghessy

Form 4 holding Executive Vice President, Chief People Officer

Seres Therapeutics, Inc.

Security class
Common Stock
Shares / value
45,684
Estimated value
$61,673
Report date
30 Oct 2023
Price
$1.35
Ownership
Direct
Form 4 holding Executive Vice President, Chief People Officer

Seres Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
9,417
Estimated value
$10,170
Report date
27 Oct 2023
Price
$1.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Executive Vice President, Chief People Officer

Seres Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
95,000
Estimated value
Report date
03 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief People Officer

Kailera Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
60,000
Estimated value
Report date
16 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Paula Cloghessy

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .